Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dehydropregnenolone Acetate
1. Dehydropregnenolone Acetate
2. 979-02-2
3. 16,17-didehydropregnenolone Acetate
4. Nsc 37741
5. 3beta-acetoxypregna-5,16-dien-20-one
6. [(3s,8r,9s,10r,13s,14s)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate
7. 832vmw7zgc
8. Chembl1761683
9. Chebi:34163
10. Nsc-37741
11. 16-dpa
12. Pregna-5,16-dien-20-one, 3-(acetyloxy)-, (3b)-
13. Pregna-5,16-dien-20-one, 3-(acetyloxy)-, (3.beta.)-
14. 3beta-acetoxy-5,16-pregnadien-20-one
15. 3.beta.-acetoxypregna-5,16-dien-20-one
16. 20-oxopregna-5,16-dien-3.beta.-yl Acetate
17. 20-oxopregna-5,16-dien-3-beta-yl Acetate
18. Einecs 213-558-7
19. Brn 1026798
20. 20-oxopregna-5,16-dien-3beta-yl Acetate
21. (3-beta)-3-(acetyloxy)pregna-5,16-dien-20-one
22. Pregna-5,16-dien-20-one, 3-beta-hydroxy-, Acetate
23. Pregnadienolone Acetate
24. 3beta-hydroxy-5,16-pregnadien-20-one Acetate
25. Unii-832vmw7zgc
26. 4-hydroxy-4-methoxybiphenyl
27. Dsstox_cid_31646
28. Dsstox_rid_97530
29. Dsstox_gsid_57857
30. 16-dehydropregnenlone Acetate
31. 4-08-00-01125 (beilstein Handbook Reference)
32. Abiraterone Related Compound 1 (pregnenolone-16-ene Acetate)
33. Pregna-5,16-dien-20-one, 3beta-hydroxy-, Acetate
34. Schembl1982395
35. Dtxsid8057857
36. Pregna-5,16-dien-20-one, 3-(acetyloxy)-, (3beta)-
37. Pregna-5,16-dien-20-one, 3.beta.-hydroxy-, Acetate
38. Pregna-5,16-dien-20-one, 3-(acetyloxy)-, (3-beta)-
39. Nsc37741
40. Zinc2105100
41. (-)-16-dehydropregnenolone Acetate
42. Tox21_113909
43. Bdbm50340426
44. Mfcd00051130
45. Akos015917345
46. Ks-1008
47. Pregna-5, 3.beta.-hydroxy-, Acetate
48. Ncgc00262911-01
49. Cas-979-02-2
50. 3beta-acetyloxy-pregna-5,16-dien-20-one
51. 5,16-pregnadien-3beta-ol-20-one Acetate
52. Pregna-5, 3-(acetyloxy)-, (3.beta.)-
53. 3.beta.-acetoxy-pregn-5,16-diene-20-one
54. 3.beta.-acetoxy-pregnan-5,16-dien-20-one
55. Cs-0015248
56. 5,16-pregnadiene-3.beta.-ol-20-one Acetate
57. Q-200100
58. 20-oxopregna-5,16-dien-3-yl Acetate, (3.beta.)-
59. Q27115857
60. (3.beta.)-3-(acetyloxy)pregna-5,16-dien-20-one
| Molecular Weight | 356.5 g/mol |
|---|---|
| Molecular Formula | C23H32O3 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 356.23514488 g/mol |
| Monoisotopic Mass | 356.23514488 g/mol |
| Topological Polar Surface Area | 43.4 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 702 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A 16-Dehydropregnenolone Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 16-Dehydropregnenolone Acetate, including repackagers and relabelers. The FDA regulates 16-Dehydropregnenolone Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 16-Dehydropregnenolone Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 16-Dehydropregnenolone Acetate supplier is an individual or a company that provides 16-Dehydropregnenolone Acetate active pharmaceutical ingredient (API) or 16-Dehydropregnenolone Acetate finished formulations upon request. The 16-Dehydropregnenolone Acetate suppliers may include 16-Dehydropregnenolone Acetate API manufacturers, exporters, distributors and traders.
16-Dehydropregnenolone Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 16-Dehydropregnenolone Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 16-Dehydropregnenolone Acetate GMP manufacturer or 16-Dehydropregnenolone Acetate GMP API supplier for your needs.
A 16-Dehydropregnenolone Acetate CoA (Certificate of Analysis) is a formal document that attests to 16-Dehydropregnenolone Acetate's compliance with 16-Dehydropregnenolone Acetate specifications and serves as a tool for batch-level quality control.
16-Dehydropregnenolone Acetate CoA mostly includes findings from lab analyses of a specific batch. For each 16-Dehydropregnenolone Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
16-Dehydropregnenolone Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (16-Dehydropregnenolone Acetate EP), 16-Dehydropregnenolone Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (16-Dehydropregnenolone Acetate USP).
LOOKING FOR A SUPPLIER?
